CStone Pharmaceuticals (CSPHF)
OTCMKTS · Delayed Price · Currency is USD
0.7029
0.00 (0.00%)
At close: Feb 9, 2026
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of $1.04 billion as of February 12, 2026. Its market cap has increased by 167.41% in one year.
Market Cap
1.04B
Enterprise Value
1.00B
Revenue
28.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.70
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 1.61B to 1.04B, a decrease of -35.28%. That is a compound annual growth rate of -6.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.05B | 5.80% |
| Dec 31, 2025 | 996.91M | 163.75% |
| Dec 31, 2024 | 377.98M | 2.10% |
| Dec 29, 2023 | 370.21M | -47.68% |
| Dec 30, 2022 | 707.54M | -42.71% |
| Dec 31, 2021 | 1.23B | -17.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |